CD44 and glioblastoma: miR-21-3p in EVs secreted by glioblastoma cells is known to promote oncogenesis, angiogenesis, and microglia activation [13] and has unanimously been described to be upregulated in the plasma of glioma patients [40], which is consistent with our data showing higher levels of miR-21-3p in glioblastoma-EVs compared to HV, as well as prognostic significance in SEC + CD44-purified EVs.